Form 4: Erasca Director Opts for Stock Options Over Cash Pay

Erasca, Inc. director Pratik S. Multani received 19,532 stock options with a $3.72 exercise price in lieu of 2026 cash compensation for board service.

Summary

• Pratik S. Multani, a Director of Erasca, Inc. (ERAS), acquired 19,532 stock options.
• These options have an exercise price of $3.72 per share.
• The grant was made on January 1, 2026, and the options expire on January 1, 2036.
• The options were issued in lieu of cash compensation for board and committee service anticipated in 2026.
• The options will vest in monthly, cumulative 1/12 increments starting one month from the grant date, contingent on continued board service.

Sentiment

Score: 7

Explanation: The director's choice to receive equity over cash compensation is generally viewed positively as it aligns their interests with long-term shareholder value, indicating confidence in the company's future.

Positives

• Director Pratik S. Multani demonstrates alignment with shareholder interests by electing to receive stock options instead of cash compensation.
• The option grant incentivizes long-term commitment and performance, as vesting is tied to continued board service.

Risks

• The value of the stock options is subject to the future performance of Erasca, Inc.'s common stock, meaning the options could become worthless if the stock price does not exceed the exercise price of $3.72.
• The vesting schedule is contingent on continued service on the board of directors, posing a risk of forfeiture if service ceases.

Future Outlook

The vesting schedule for the stock options extends over a period, indicating an expectation of continued board service by Pratik S. Multani through the applicable vesting dates.

Management Comments

• At the election of the filing person the option grant was issued in lieu of the cash compensation payable to such person in 2026 in connection with each position on the issuer's board of directors and its committees for which such person is anticipated to serve in 2026.
• The option will vest and become exercisable in monthly, cumulative 1/12 increments beginning one month from the date of grant, subject to such person continuing to serve on the issuer's board of directors through the applicable vesting date.

Industry Context

This Form 4 filing reflects a common practice in the biotechnology and pharmaceutical industry where executive and director compensation often includes equity components like stock options to align leadership interests with long-term company performance and shareholder value.

Comparison to Industry Standards

• This type of equity compensation, where directors elect to receive options in lieu of cash, is a standard practice across many growth-oriented companies, particularly in the biotech sector.
• It aligns director incentives with shareholder value creation, similar to practices seen at companies like Moderna or BioNTech, where significant portions of executive and director compensation are equity-based to encourage long-term commitment and innovation.

Related Party Transactions

• The stock option grant to Director Pratik S. Multani in lieu of cash compensation for his board service constitutes a related party transaction, as it involves compensation provided by the issuer to a member of its board of directors.

Stakeholder Impact

• Shareholders: Potentially positive, as director's interests are more aligned with long-term stock performance. Dilution risk is minimal from this single grant but exists if many options are exercised.
• Employees: No direct impact mentioned.
• Customers: No direct impact mentioned.
• Suppliers: No direct impact mentioned.
• Creditors: No direct impact mentioned.

Next Steps

• Pratik S. Multani will continue to serve on Erasca, Inc.'s board of directors to ensure the full vesting of the granted stock options.
• The options will vest in monthly increments, requiring ongoing monitoring of the vesting schedule.

Key Dates

Recommendation

This Form 4 filing details a routine compensation event where a director elected to receive stock options instead of cash. While this indicates alignment of interests and confidence from the director, it does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment recommendation. It's a neutral event from an investment decision perspective, hence a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Erasca, ERAS, Form 4, Insider Trading, Stock Options, Director Compensation, Equity Compensation, Beneficial Ownership, Pratik S. Multani